These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9123114)

  • 1. Hepatitis C virus genotypes and severe hepatitis C virus recurrence after liver transplantation.
    Alberti AB; Belli LS; Silini E; Zavaglia C; Iamoni G; Rondinara GF; De Carlis L; Forti D; Ideo G
    Transplant Proc; 1997; 29(1-2):522-3. PubMed ID: 9123114
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatitis C virus infection after liver transplantation: clinical and virological features.
    Crespo J; Carte B; Casafont F; Fábrega E; de las Heras G; de la Peña J; Pons-Romero F
    Transplant Proc; 1997; 29(1-2):524-5. PubMed ID: 9123115
    [No Abstract]   [Full Text] [Related]  

  • 3. Quantitation of hepatitis C virus RNA in liver tissue of allografts: correlation with histologic features and liver function tests.
    Aardema KL; Nakhleh RE; Terry LK; Burd EM; Ma CK; Moonka DK; Brown KA; Abouljoud MS
    Transplant Proc; 1999; 31(1-2):477-8. PubMed ID: 10083198
    [No Abstract]   [Full Text] [Related]  

  • 4. Hepatitis C virus genotypes and quantification of serum hepatitis C RNA in liver transplant recipients. Relationship with histologic outcome of recurrent hepatitis C.
    Costes V; Durand L; Pageaux GP; Ducos J; Mondain AM; Picot MC; Domergue J; Larrey D; Baldet P
    Am J Clin Pathol; 1999 Feb; 111(2):252-8. PubMed ID: 9930149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrent hepatitis C infection after orthotopic liver transplantation.
    Knoop M; Bechstein WO; Blumhardt G; Langrehr JM; Berg T; König V; Wedell A; Hopf U; Neuhaus P
    Transplant Proc; 1995 Feb; 27(1):1208-10. PubMed ID: 7878852
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of steroids amount on hepatitis C recurrence following orthtopic liver transplantation.
    Tisone G; Laria G; Orlando G; Pisani F; Palmieri GP; Bellanova G; Torri E; Buonomo O; Angelico M; Casciani CU
    Transplant Proc; 1999 Dec; 31(8):3167-8. PubMed ID: 10616427
    [No Abstract]   [Full Text] [Related]  

  • 7. Hepatitis C recurrence in liver transplant recipients.
    Kizilisik TA; al-Sebayel M; Hammad A; al-Traif I; Ramirez CG; Abdulla A
    Transplant Proc; 1997 Nov; 29(7):2875-7. PubMed ID: 9365599
    [No Abstract]   [Full Text] [Related]  

  • 8. Hepatitis C viral infection and adult liver transplantation: a difficult clinical problem.
    Donataccio M; Lerut J; Ciccarelli O; Cornu C; Laterre PF; Geubel A; Otte JB
    Transplant Proc; 1994 Dec; 26(6):3588-90. PubMed ID: 7998284
    [No Abstract]   [Full Text] [Related]  

  • 9. Histological and clinical outcome after liver transplantation for hepatitis C.
    Shuhart MC; Bronner MP; Gretch DR; Thomassen LV; Wartelle CF; Tateyama H; Emerson SS; Perkins JD; Carithers RL
    Hepatology; 1997 Dec; 26(6):1646-52. PubMed ID: 9398011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. European collaborative study on factors influencing outcome after liver transplantation for hepatitis C. European Concerted Action on Viral Hepatitis (EUROHEP) Group.
    Féray C; Caccamo L; Alexander GJ; Ducot B; Gugenheim J; Casanovas T; Loinaz C; Gigou M; Burra P; Barkholt L; Esteban R; Bizollon T; Lerut J; Minello-Franza A; Bernard PH; Nachbaur K; Botta-Fridlund D; Bismuth H; Schalm SW; Samuel D
    Gastroenterology; 1999 Sep; 117(3):619-25. PubMed ID: 10464137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C reinfection after liver transplantation in relation to virus genotype.
    Tisone G; Baiocchi L; Orlando G; Palmieri GP; Pisani F; Rapicetta M; Strati F; Anselmo A; Torri E; Bellanova G; Casciani CU; Angelico M
    Transplant Proc; 1999; 31(1-2):490-1. PubMed ID: 10083205
    [No Abstract]   [Full Text] [Related]  

  • 12. Recurrent hepatitis C infection following orthotopic liver transplantation is predicted by posttransplant serum and hepatic allograft viral titers.
    Cirocco R; Fragulidis GP; Weppler D; Zucker K; Markou M; Zervos XA; Viciana A; Esquinazi V; Nery JR; Reddy KR; Schiff E; Miller J; Tzakis AG
    Transplant Proc; 1997 Nov; 29(7):2839-40. PubMed ID: 9365583
    [No Abstract]   [Full Text] [Related]  

  • 13. Indication for mycophenolate mofetil therapy in hepatitis C patients undergoing liver transplantation.
    Platz KP; Mueller AR; Willimski C; Mansoorian B; Berg T; Neuhaus R; Hopf U; Radke C; Neuhaus P
    Transplant Proc; 1998 Aug; 30(5):2232-3. PubMed ID: 9723453
    [No Abstract]   [Full Text] [Related]  

  • 14. Impact of the recurrence of hepatitis C virus infection after liver transplantation on the long-term viability of the graft.
    Sánchez-Fueyo A; Restrepo JC; Quintó L; Bruguera M; Grande L; Sánchez-Tapias JM; Rodés J; Rimola A
    Transplantation; 2002 Jan; 73(1):56-63. PubMed ID: 11792978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for recurrence of hepatitis C after liver transplantation.
    Herrero JI; de la Peña A; Quiroga J; Sangro B; García N; Sola I; Cienfuegos JA; Civeira MP; Prieto J
    Liver Transpl Surg; 1998 Jul; 4(4):265-70. PubMed ID: 9649638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Course of the recurrence of hepatitis C virus infection after liver transplantation].
    Gugenheim J; Baldini E; Ouzan D; Mazza D; Saint-Paul MC; Goubaux B; Mouiel J
    Gastroenterol Clin Biol; 1996; 20(10):730-5. PubMed ID: 8991141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenetic factors, HCV genotypes, and HCV recurrence after liver transplantation.
    Belli LS; Zavaglia C; Alberti AB; Rondinara GF; De Carlis L; Silini E; Poli F; Scalamogna M; Tinelli C; Forti D; Ideo G
    Transplant Proc; 1999; 31(1-2):483-4. PubMed ID: 10083201
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of interferon treatment on liver histology and allograft rejection in patients with recurrent hepatitis C following liver transplantation.
    Stravitz RT; Shiffman ML; Sanyal AJ; Luketic VA; Sterling RK; Heuman DM; Ashworth A; Mills AS; Contos M; Cotterell AH; Maluf D; Posner MP; Fisher RA
    Liver Transpl; 2004 Jul; 10(7):850-8. PubMed ID: 15237368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantification of C4d deposition and hepatitis C virus RNA in tissue in cases of graft rejection and hepatitis C recurrence after liver transplantation.
    Song AT; Mello ES; Alves VA; Cavalheiro Nde P; Melo CE; Bonazzi PR; Tengan FM; Freire MP; Barone AA; D'Albuquerque LA; Abdala E
    Mem Inst Oswaldo Cruz; 2015 Feb; 110(1):56-64. PubMed ID: 25742264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective evaluation of fibrosis progression in patients with recurrent hepatitis C virus following liver transplantation.
    Yilmaz N; Shiffman ML; Stravitz RT; Sterling RK; Luketic VA; Sanyal AJ; Mills AS; Contos MJ; Coterell A; Maluf D; Posner MP; Fisher RA
    Liver Transpl; 2007 Jul; 13(7):975-83. PubMed ID: 17600360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.